Activity and safety of KEES - an oral multi-drug chemo-hormonal metronomic combination regimen in metastatic castration-resistant prostate cancer

BACKGROUND: Metastatic castration-resistant prostate cancer (mCRPC) remains a therapeutic challenge and evidence for late-line treatments in real-life is limited. The present study investigates the efficacy and safety of an oral metronomic chemo-hormonal regimen including cyclophosphamide, etoposide...

Descripción completa

Detalles Bibliográficos
Autores principales: Asowed, Mustafa, Elander, Nils O, Pettersson, Linn, Ekholm, Maria, Papantoniou, Dimitrios
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10074662/
https://www.ncbi.nlm.nih.gov/pubmed/37016322
http://dx.doi.org/10.1186/s12885-023-10780-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10074662/
https://www.ncbi.nlm.nih.gov/pubmed/37016322
http://dx.doi.org/10.1186/s12885-023-10780-y

Ejemplares similares